Search Results - "Coel, Marc N"

Refine Results
  1. 1

    Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging by Kwee, Sandi A., Coel, Marc N., Lim, John

    Published in Annals of nuclear medicine (01-07-2012)
    “…Purpose To evaluate fluorine-18 fluorocholine (FCH) PET/CT for the detection of recurrent prostate cancer in relation to prostate-specific antigen (PSA) level…”
    Get full text
    Journal Article
  2. 2

    Cancer Imaging With Fluorine-18–Labeled Choline Derivatives by Kwee, Sandi A., MD, DeGrado, Timothy R., PhD, Talbot, Jean Noel, MD, Gutman, Fabrice, MD, Coel, Marc N., MD

    Published in Seminars in nuclear medicine (01-11-2007)
    “…The choline transporter and choline kinase enzyme frequently are overexpressed in malignancy. Therefore, positron-emitter-labeled compounds derived from…”
    Get full text
    Journal Article
  3. 3

    (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer by Kwee, Sandi A, Coel, Marc N, Ly, Bevan H, Lim, John

    Published in Annals of nuclear medicine (01-08-2009)
    “…Apply measurability criteria based on the response evaluation criteria in solid tumors (RECIST) to lesions found on (18)F-choline positron emission tomography…”
    Get full text
    Journal Article
  4. 4

    Soft Tissue Response on 18F-Fluorocholine PET/CT in Metastatic Castrate-Resistant Prostate Cancer Treated With 223Ra-Dichloride: A Possible Abscopal Effect? by Kwee, Sandi A, Lim, John, Coel, Marc N

    Published in Clinical nuclear medicine (01-11-2017)
    “…ABSTRACTTwo patients with castrate-resistant prostate cancer and symptomatic skeletal metastases underwent F-fluorocholine PET/CT prior to treatment with…”
    Get full text
    Journal Article
  5. 5

    18F-choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer by Kwee, Sandi A., Coel, Marc N., Ly, Bevan H., Lim, John

    Published in Annals of nuclear medicine (01-08-2009)
    “…Purpose Apply measurability criteria based on the response evaluation criteria in solid tumors (RECIST) to lesions found on 18 F-choline positron emission…”
    Get full text
    Journal Article
  6. 6

    Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET by Kwee, Sandi A, Ko, Jehoon P, Jiang, Caroline S, Watters, Michael R, Coel, Marc N

    Published in Radiology (01-08-2007)
    “…To prospectively determine whether differences between benign and malignant brain lesions can be depicted with fluorine 18 ((18)F) fluorocholine positron…”
    Get more information
    Journal Article
  7. 7

    The effects of ice on blood flow and bone metabolism in knees by Ho, S S, Coel, M N, Kagawa, R, Richardson, A B

    Published in The American journal of sports medicine (01-07-1994)
    “…The effects of an ice wrap, applied to a knee for 20 minutes, on blood flow and bone metabolism were measured using triple-phase technetium bone scans…”
    Get more information
    Journal Article
  8. 8

    Detection of Synchronous Primary Breast and Prostate Cancer by F-18 Fluorocholine PET/CT by Kwee, Sandi A, Coel, Marc N

    Published in Clinical nuclear medicine (01-02-2010)
    “…There is growing experience with F-18 fluorocholine (FCH) for positron emission tomography/computed tomography (PET/CT) imaging of prostate cancer, but limited…”
    Get full text
    Journal Article
  9. 9

    Use of Step-Section Histopathology to Evaluate F-Fluorocholine PET Sextant Localization of Prostate Cancer by Sandi A. Kwee, Gregory P. Thibault, Richard S. Stack, Marc N. Coel, Bungo Furusato, Isabell A. Sesterhenn

    Published in Molecular imaging (01-01-2008)
    “…To assess positron emission tomography (PET) with fluorine-18 fluorocholine for sextant localization of malignant prostate tumors. Histopathologic analysis was…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Prostate cancer localization with 18fluorine fluorocholine positron emission tomography by Kwee, Sandi A, Coel, Marc N, Lim, John, Ko, Jehoon P

    Published in The Journal of urology (01-01-2005)
    “…We evaluated positron emission tomography (PET) with fluorine fluorocholine (F FCH) for the pretreatment localization of prostate cancer. A total of 17…”
    Get more information
    Journal Article
  12. 12

    Use of Step-Section Histopathology to Evaluate 18F-Fluorocholine PET Sextant Localization of Prostate Cancer by Kwee, Sandi A., Thibault, Gregory P., Stack, Richard S., Coel, Marc N., Furusato, Bungo, Sesterhenn, Isabell A.

    Published in Molecular imaging (01-01-2008)
    “…To assess positron emission tomography (PET) with fluorine-18 fluorocholine for sextant localization of malignant prostate tumors. Histopathologic analysis was…”
    Get full text
    Journal Article
  13. 13

    Combined Use of F-18 Fluorocholine Positron Emission Tomography and Magnetic Resonance Spectroscopy for Brain Tumor Evaluation by Kwee, Sandi A., Coel, Marc N., Lim, John, Ko, Jehoon P.

    Published in Journal of neuroimaging (01-07-2004)
    “…ABSTRACT Background. Choline metabolism is often abnormal in malignant brain tumors.Methods. Brain positron emission tomography (PET) imaging with F‐18…”
    Get full text
    Journal Article
  14. 14

    Lack of effect of particle size on the identification of the sentinel node in cutaneous malignancies by Wong, J H, Terada, K, Ko, P, Coel, M N

    Published in Annals of surgical oncology (01-01-1998)
    “…Radiotracers have become a routine technical component of the new procedure of intraoperative lymphatic mapping and selective lymphadenectomy. Because…”
    Get full text
    Journal Article
  15. 15

    Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by super( 18)F-Fluorocholine PET/CT by Lee, Joohee, Sato, Miles M, Coel, Marc N, Lee, Kyung-Han, Kwee, Sandi A

    Published in The Journal of nuclear medicine (1978) (01-07-2016)
    “…Measurements of metabolically active tumor volume (MATV) can be applied to super( 18)F-fluorocholine PET/CT to quantify whole-body tumor burden. This study…”
    Get full text
    Journal Article
  16. 16

    Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by ^sup 18^F-Fluorocholine PET/CT by Lee, Joohee, Sato, Miles M, Coel, Marc N, Lee, Kyung-Han, Kwee, Sandi A

    Published in The Journal of nuclear medicine (1978) (01-07-2016)
    “…Measurements of metabolically active tumor volume (MATV) can be applied to ^sup 18^F-fluorocholine PET/CT to quantify whole-body tumor burden. This study…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Prediction of PSA progression in castrate-resistant prostate cancer based on treatment-associated change in tumor burden quantified by 18F-fluorocholine PET/CT by Lee, Joohee, Sato, Miles M., Coel, Marc N., Lee, Kyung-Han, Kwee, Sandi A.

    Published in The Journal of nuclear medicine (1978) (16-02-2016)
    “…Metabolically active tumor volume (MATV) measurements can be applied to 18 F-fluorocholine positron emission tomography/computed tomography (PET/CT) to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Current Imaging and Possible Therapeutic Management of Glucagonoma Tumors: A Case Report by JOHNSON, DAVID SCOTT, COEL, MARC N, BORNEMANN, MICHAEL

    Published in Clinical nuclear medicine (01-02-2000)
    “…Glucagonomas, like other neuroendocrine tumors, express somatostatin receptors in more than 80% of cases. Unfortunately, because of the rarity of these tumors,…”
    Get full text
    Journal Article